These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 36540936
21. Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6. Feng X, Wei G, Su Y, Xian Y, Liu Z, Gao Y, Liang J, Lian H, Xu J, Zhao J, Liu Q, Song F. Phytomedicine; 2024 Sep; 132():155890. PubMed ID: 39033726 [Abstract] [Full Text] [Related]
22. Zanthoxylum piperitum alleviates the bone loss in osteoporosis via inhibition of RANKL-induced c-fos/NFATc1/NF-κB pathway. Kim MH, Lee H, Ha IJ, Yang WM. Phytomedicine; 2021 Jan; 80():153397. PubMed ID: 33130475 [Abstract] [Full Text] [Related]
23. Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption. Li S, Teguh D, Wu D, Liu L, Hu C, Yuan J, Inderjeeth CA, Xu J. J Cell Physiol; 2023 Aug; 238(8):1823-1835. PubMed ID: 37334837 [Abstract] [Full Text] [Related]
29. Inhibition of PPP1R15A alleviates osteoporosis via suppressing RANKL-induced osteoclastogenesis. Ding ZB, Chen Y, Zheng YR, Wang YY, Deng WD, Zheng JH, Yang Q, Chen ZY, Li LH, Jiang H, Li XJ. Acta Pharmacol Sin; 2024 Apr; 45(4):790-802. PubMed ID: 38191913 [Abstract] [Full Text] [Related]
30. Tectorigenin inhibits RANKL-induced osteoclastogenesis via suppression of NF-κB signalling and decreases bone loss in ovariectomized C57BL/6. Ma C, Xu K, Meng J, Ran J, Adel Abdo Moqbel S, Liu A, Yan S, Wu L. J Cell Mol Med; 2018 Oct; 22(10):5121-5131. PubMed ID: 30063119 [Abstract] [Full Text] [Related]
33. Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways. Wang G, Chen K, Ma C, Wang C, Chen D, He J, Liu Y, Jiang T, Yuan J, Chen L, He W, Xu J. J Cell Physiol; 2022 Mar; 237(3):1790-1803. PubMed ID: 34796915 [Abstract] [Full Text] [Related]
34. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways. Song J, Jing Z, Hu W, Yu J, Cui X. Med Sci Monit; 2017 Oct 24; 23():5056-5069. PubMed ID: 29061958 [Abstract] [Full Text] [Related]
35. Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways. Cang D, Zou G, Yang C, Shen X, Li F, Wu Y, Ji B. J Pharmacol Sci; 2021 Aug 24; 146(4):206-215. PubMed ID: 34116734 [Abstract] [Full Text] [Related]
37. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways. Yuan FL, Xu RS, Jiang DL, He XL, Su Q, Jin C, Li X. Bone; 2015 Jun 24; 75():128-37. PubMed ID: 25708053 [Abstract] [Full Text] [Related]
38. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways. Liou SF, Hsu JH, Lin IL, Ho ML, Hsu PC, Chen LW, Chen IJ, Yeh JL. PLoS One; 2013 Jun 24; 8(7):e69468. PubMed ID: 23936022 [Abstract] [Full Text] [Related]
39. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption. Mei L, Sang W, Chen Z, Zheng L, Jin K, Lou C, Huang W, He D. J Cell Physiol; 2018 Dec 24; 233(12):9724-9738. PubMed ID: 30059597 [Abstract] [Full Text] [Related]
40. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities. Joung YH, Darvin P, Kang DY, Sp N, Byun HJ, Lee CH, Lee HK, Yang YM. PLoS One; 2016 Dec 24; 11(7):e0159891. PubMed ID: 27447722 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]